Data Characteristics
mRNA vaccine product data primarily originates from clinical trial reports, regulatory submission documents, manufacturing process specifications, quality control standards, and academic research papers. These documents undergo frequent updates, especially during early development and market launch. Document structures typically include extensive specialized terminology, biochemical reaction pathway diagrams, dosage curve charts, clinical data statistical tables, and complex molecular structures. Fields often involve nucleotide sequences, modified base types, lipid nanoparticle (LNP) components, vaccine potency, immunogenicity indicators, and adverse event rates. Units cover micrograms (µg), nanomoles (nmol), IU/mL (International Units/milliliter), percentages (%), and various statistical units (e.g., P-values, confidence intervals).
Constraints Imposed by Data Characteristics on "Document Parsing and Chunking"
The specialized and complex nature of mRNA vaccine product documents requires accurate identification and extraction of key information during the document parsing phase. For example, non-text content like nucleotide sequences and molecular structure diagrams requires assistance from image recognition or OCR technology. High update frequency means the knowledge base needs frequent incremental updates and version management to ensure information timeliness. The large number of specialized terms and abbreviations in documents can lead to semantic understanding deviations in general word tokenizers, necessitating customized dictionary support. Furthermore, the presence of charts and complex tables means that simple text chunking methods are insufficient to capture complete semantics. This may require considering the association between charts and text for chunking, or structured extraction of table content. Accurate unit recognition is critical for the precision of key information such as dosage and potency.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunking Strategy | Paragraph Chunking + Table Structuring | mRNA vaccine documents are primarily natural paragraphs; table content is information-dense and requires separate processing. |
Max Chunk Size | 800–1200 characters | Balances contextual completeness with retrieval efficiency, preventing single chunks from diluting the topic. |
Min Chunk Size | 100 characters | Filters out overly short, information-poor chunks, reducing noise. |
Model Recognition Paragraph Depth | 3 | mRNA vaccine document hierarchies typically do not exceed three levels, balancing title and body text association. |
Custom Dictionary | mRNA Vaccine Terminology Database | Improves recognition accuracy for specialized terms like mRNA sequences and LNP components. |
Image OCR | Enabled | Extracts text information from non-textual molecular structure diagrams and flowcharts. |
Common Pitfalls
- Vaccine dosage or LNP component data is missing from parsing results because this information often appears in tables or figure captions and is not recognized by pure text parsers.
- AI responses regarding specific gene sequences or modified bases are inaccurate because general word tokenizers do not treat these specialized sequences as a whole, leading to incorrect truncation during chunking.
- Updated clinical trial reports are not reflected in the knowledge base promptly because document monitoring or incremental update mechanisms are not optimized for high-frequency update sources, leading to information lag.
How to Verify Configuration
- Randomly select 5 mRNA vaccine product documents from different sources. Check if key nucleotide sequences, dosage information, and adverse event tables are fully retained after parsing.
- Compare parsed chunks against original documents to verify semantic coherence. Ensure no critical information is truncated or taken out of context, especially descriptions involving complex biochemical processes.
- Use queries containing specific mRNA vaccine specialized terms. Check if recall results accurately hit chunks containing these terms and evaluate the contextual completeness of the recalled chunks.
The values provided are common starting points and should be measured against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.